Clinical Research

Active clinical trials of new anticancer drugs include kinase inhibitors, and antibodies activating the T-cell regulating CD27 pathway and the macrophage regulating CD47 pathway.

For more information, please contact the Stanford Center for Clinical and Translational Research and Education (Spectrum)

The Jill and John Freidenrich Center for Translational Research (FCTR) at Stanford University